Literature DB >> 20533778

Prostate cancer screening 2010: updated recommendations from the American Cancer Society.

Durado D Brooks1, Andrew Wolf, Robert A Smith, Chiranjeev Dash, Idris Guessous.   

Abstract

In 2009, the American Cancer Society (ACS) initiated a series of systematic evidence reviews to update recommendations for early prostate cancer detection. The evidence reviews focused on studies of screening, the performance of screening tests, harms associated with testing and therapy for localized prostate cancer, and shared and informed decision making in prostate cancer screening. Based on this evidence, the ACS recommends that asymptomatic men who have at least a 10-year life expectancy have an opportunity to make an informed decision with their health care provider about screening for prostate cancer after receiving information about the uncertainties, risks, and potential benefits associated with prostate cancer screening. Prostate cancer screening should not occur without an informed decision-making process. Men at average risk should receive this information beginning at age 50. Men in higher-risk groups should receive this information before age 50. Men should either receive this information directly from their health care providers or be referred to reliable and culturally appropriate sources. Patient decision aids are helpful in preparing men to make a decision whether to be tested, and the use of such aids is encouraged.

Entities:  

Mesh:

Year:  2010        PMID: 20533778     DOI: 10.1016/s0027-9684(15)30578-2

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  13 in total

1.  Patterns of information behavior and prostate cancer knowledge among African-American men.

Authors:  Levi Ross; Tyra Dark; Heather Orom; Willie Underwood; Charkarra Anderson-Lewis; Jarrett Johnson; Deborah O Erwin
Journal:  J Cancer Educ       Date:  2011-12       Impact factor: 2.037

2.  Prostate-specific antigen test for prostate cancer screening: American Society of Clinical Oncology provisional clinical opinion.

Authors:  Robert K Nam; Thomas K Oliver; Andrew J Vickers; Ian Thompson; Philip W Kantoff; Howard L Parnes; Andrew Loblaw; Bruce J Roth; Jim Williams; Sarah Temin; Ethan Basch
Journal:  J Oncol Pract       Date:  2012-09       Impact factor: 3.840

3.  Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion.

Authors:  Ethan Basch; Thomas K Oliver; Andrew Vickers; Ian Thompson; Philip Kantoff; Howard Parnes; D Andrew Loblaw; Bruce Roth; James Williams; Robert K Nam
Journal:  J Clin Oncol       Date:  2012-07-16       Impact factor: 44.544

Review 4.  [Prostate biopsy. Update for indication, procedure, and future developments].

Authors:  S Machtens; A Roosen; C G Stief; M C Truß
Journal:  Urologe A       Date:  2014-07       Impact factor: 0.639

5.  Talking About Your Prostate: Perspectives from Providers and Community Members.

Authors:  Seul Ki Choi; Jessica S Seel; Susan E Steck; Johnny Payne; Douglas McCormick; Courtney S Schrock; Daniela B Friedman
Journal:  J Cancer Educ       Date:  2018-10       Impact factor: 2.037

6.  African american primary care physicians' prostate cancer screening practices.

Authors:  Louie E Ross; Ingrid J Hall
Journal:  J Prim Care Community Health       Date:  2013-10-17

7.  Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer.

Authors:  Sharanjot Saini; Shahana Majid; Varahram Shahryari; Z Laura Tabatabai; Sumit Arora; Soichiro Yamamura; Yuichiro Tanaka; Rajvir Dahiya; Guoren Deng
Journal:  Mol Cancer Ther       Date:  2014-05-09       Impact factor: 6.261

8.  Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.

Authors:  Bryan Leyva; Alexander Persoskie; Allison Ottenbacher; Jada G Hamilton; Jennifer D Allen; Sarah C Kobrin; Stephen H Taplin
Journal:  J Cancer Educ       Date:  2016-12       Impact factor: 2.037

Review 9.  PSA and beyond: alternative prostate cancer biomarkers.

Authors:  Sharanjot Saini
Journal:  Cell Oncol (Dordr)       Date:  2016-01-20       Impact factor: 6.730

Review 10.  From bench to bedside: the realities of reducing global prostate cancer disparity in black men.

Authors:  Robin Roberts
Journal:  Ecancermedicalscience       Date:  2014-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.